Nina Heldring
Papers
1
Total Citations
80
H-Index
1
About
Nina Heldring is a structural biologist whose research has fundamentally advanced our understanding of nuclear receptor signaling, particularly the estrogen receptors (ERα and ERβ). Her major contributions lie in elucidating the molecular mechanisms by which clinically important ER antagonists exert their tissue-specific effects. In her landmark 2007 study, which has garnered 80 citations, Heldring solved the crystal structures of corepressor peptides bound to antagonist-occupied ERα. This work provided the first direct structural evidence for how antagonist binding creates a surface that recruits transcriptional corepressors, offering a mechanistic explanation for the selective modulation observed in drugs like tamoxifen. By revealing the precise atomic interactions governing this corepressor recognition, Heldring’s research has profound implications for designing next-generation selective estrogen receptor modulators (SERMs) with improved therapeutic profiles. Her structural insights continue to guide drug discovery efforts in breast cancer and endocrine disorders, establishing her as a key figure in the field of steroid hormone receptor biology.
Research Focus
Key Achievements
Top Papers
- 1